91 related articles for article (PubMed ID: 21897271)
1. Analysis of 4 single-nucleotide polymorphisms in relation to cervical dysplasia and cancer development using a high-throughput ligation-detection reaction procedure.
von Keyserling H; Bergmann T; Schuetz M; Schiller U; Stanke J; Hoffmann C; Schneider A; Lehrach H; Dahl A; Kaufmann AM
Int J Gynecol Cancer; 2011 Dec; 21(9):1664-71. PubMed ID: 21897271
[TBL] [Abstract][Full Text] [Related]
2. MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women.
González-Herrera L; Rodríguez-Morales P; Gonza Lez-Losa Mdel R; Pérez-Mendoza G; Canul-Canché J; Rosado-López I; Cetina TC
Int J Biol Markers; 2014 Jun; 29(2):e142-9. PubMed ID: 24474455
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women.
Silva NNT; Sabino AP; Tafuri A; Lima AA
BMC Med Genet; 2019 Jun; 20(1):100. PubMed ID: 31170928
[TBL] [Abstract][Full Text] [Related]
4. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
Joseph T; Chacko P; Wesley R; Jayaprakash PG; James FV; Pillai MR
Gynecol Oncol; 2006 Jun; 101(3):411-7. PubMed ID: 16360200
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.
Nath N; Mishra P; Panda AK; Mishra R
Int Immunopharmacol; 2020 Nov; 88():106925. PubMed ID: 32871478
[TBL] [Abstract][Full Text] [Related]
6. Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily.
Agodi A; Barchitta M; Cipresso R; Marzagalli R; La Rosa N; Caruso M; Castiglione MG; Travali S
Int J Gynecol Cancer; 2010 Jan; 20(1):141-6. PubMed ID: 20130515
[TBL] [Abstract][Full Text] [Related]
7. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection.
Chansaenroj J; Theamboonlers A; Junyangdikul P; Swangvaree S; Karalak A; Chinchai T; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(1):341-6. PubMed ID: 23534750
[TBL] [Abstract][Full Text] [Related]
9. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
[TBL] [Abstract][Full Text] [Related]
10. The Association of CYP1A1 Gene With Cervical Cancer and Additional SNP-SNP Interaction in Chinese Women.
Li S; Li G; Kong F; Liu Z; Li N; Li Y; Guo X
J Clin Lab Anal; 2016 Nov; 30(6):1220-1225. PubMed ID: 27265845
[TBL] [Abstract][Full Text] [Related]
11. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.
Goodman MT; McDuffie K; Hernandez B; Wilkens LR; Bertram CC; Killeen J; Le Marchand L; Selhub J; Murphy S; Donlon TA
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1275-80. PubMed ID: 11751445
[TBL] [Abstract][Full Text] [Related]
12. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
[TBL] [Abstract][Full Text] [Related]
13. TP53, MDM2, NQO1, and susceptibility to cervical cancer.
Hu X; Zhang Z; Ma D; Huettner PC; Massad LS; Nguyen L; Borecki I; Rader JS
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):755-61. PubMed ID: 20200430
[TBL] [Abstract][Full Text] [Related]
14. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
[TBL] [Abstract][Full Text] [Related]
15. Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.
Lima G; Santos E; Angelo H; Oliveira M; Heráclio S; Leite F; de Melo C; Crovella S; Maia M; Souza P
Tumour Biol; 2016 Aug; 37(8):10935-41. PubMed ID: 26886286
[TBL] [Abstract][Full Text] [Related]
16. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
17. The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women.
Sull JW; Jee SH; Yi S; Lee JE; Park JS; Kim S; Ohrr H
Gynecol Oncol; 2004 Dec; 95(3):557-63. PubMed ID: 15581963
[TBL] [Abstract][Full Text] [Related]
18. The effect of methylenetetrahydrofolate reductase polymorphisms on susceptibility to human papilloma virus infection and cervical cancer.
Hajiesmaeil M; Tafvizi F; Sarmadi S
Infect Genet Evol; 2016 Dec; 46():1-6. PubMed ID: 27771518
[TBL] [Abstract][Full Text] [Related]
19. A case-control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis.
Rao GG; Kurien A; Gossett D; Griffith WF; Coleman RL; Muller CY
Gynecol Oncol; 2006 May; 101(2):250-4. PubMed ID: 16297972
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
